Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case-Control Database Study.
Marco SolmiMarkku LähteenvuoAntti TanskanenOlivier CorbeilEllenor Mittendorfer-RutzChristoph U CorrellJari TiihonenHeidi TaipalePublished in: Schizophrenia bulletin (2024)
Although causality remains uncertain, exposure to prolactin-elevating antipsychotics for ≥ 1 year was associated with increased odds of breast cancer in women with severe mental illness. When prescribing antipsychotics, a shared decision-making process should consider individual risk factors for breast cancer.